日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In Search of Beautiful Molecules: A Perspective on Generative Modeling for Drug Design

探寻美丽的分子:药物设计生成建模的视角

van den Broek, Remco L; Patel, Shivam; van Westen, Gerard J P; Jespers, Willem; Sherman, Woody

HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors

HLA-E/肽复合物与NKG2A/CD94和T细胞受体的相互作用存在差异。

Voogd, Linda; van den Broek, Remco L; van Wolfswinkel, Marjolein; Franken, Kees L M C; Ruibal, Paula; Jespers, Willem; Leitner, Judith; Steinberger, Peter; van Westen, Gerard J P; Ottenhoff, Tom H M; Joosten, Simone A

QSPRpred: a Flexible Open-Source Quantitative Structure-Property Relationship Modelling Tool

QSPRpred:一款灵活的开源定量结构-性质关系建模工具

van den Maagdenberg, Helle W; Šícho, Martin; Araripe, David Alencar; Luukkonen, Sohvi; Schoenmaker, Linde; Jespers, Michiel; Béquignon, Olivier J M; González, Marina Gorostiola; van den Broek, Remco L; Bernatavicius, Andrius; van Hasselt, J G Coen; van der Graaf, Piet H; van Westen, Gerard J P

Memprot.GPCR-ModSim: modelling and simulation of membrane proteins in a nutshell

Memprot.GPCR-ModSim:膜蛋白建模与仿真简述

van den Broek, Remco L; Bello, Xabier; Küpper, Rebecca V; van Westen, Gerard J P; Jespers, Willem; Gutiérrez-de-Terán, Hugo

3DDPDs: describing protein dynamics for proteochemometric bioactivity prediction. A case for (mutant) G protein-coupled receptors

3DDPDs:用于蛋白质化学计量学生物活性预测的蛋白质动力学描述。以(突变型)G蛋白偶联受体为例

Gorostiola González, Marina; van den Broek, Remco L; Braun, Thomas G M; Chatzopoulou, Magdalini; Jespers, Willem; IJzerman, Adriaan P; Heitman, Laura H; van Westen, Gerard J P

Anterior Cruciate Ligament Rehabilitation for the 10- to 18-Year-Old Adolescent Athlete: Practice Guidelines Based on International Delphi Consensus

10至18岁青少年运动员前交叉韧带康复:基于国际德尔菲共识的实践指南

van Melick, Nicky; Dietvorst, Martijn; van Oort, Maaike I A M; Claessens, Remco L A; Janssen, Rob P A; Bogie, Rob; Claussen, William; Greenberg, Elliot M; Grindem, Hege; Kearney, Sharon; van Keulen, Matthijs; Lips, Martijn; Macrina, Lenny; McWilliam, David; Moksnes, Håvard; Norris, Richard; Paterno, Mark V; Picot, Brice; Piskulic, David; Prato, Luis F; Sayer, Timothy A; Sethi, Faraz; Silvers-Granelli, Holly; Truong, Linda; Whalan, Matthew; Witvrouw, Erik

Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact

反思医药公私合作的未来:从投入到影响

de Vrueh, Remco L A; Crommelin, Daan J A

Drug development for exceptionally rare metabolic diseases: challenging but not impossible

针对极其罕见的代谢疾病的药物研发:充满挑战,但并非不可能

Putzeist, Michelle; Mantel-Teeuwisse, Aukje K; Wied, Christine C Gispen-de; Hoes, Arno W; Leufkens, Hubert G M; de Vrueh, Remco L A

Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?

市场独占权是否阻碍了欧洲后续孤儿药产品的开发?

Brabers, Anne E M; Moors, Ellen H M; van Weely, Sonja; de Vrueh, Remco L A

Predictors of orphan drug approval in the European Union

欧盟孤儿药批准的预测因素

Heemstra, Harald E; de Vrueh, Remco L; van Weely, Sonja; Büller, Hans A; Leufkens, Hubert G M